Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily-and steps pharma can take to secure and protect its own data.
Shelby Buettner
Advertisement
Shelby Buettner is an associate at McDermott Will & Emery. She advises pharma, medical device, and healthcare companies on FDA regulatory and compliance matters.
Articles by Shelby Buettner
Navigating Data Privacy and Security Considerations in the Life Sciences Industry
Advertisement
Latest Updated Articles
- When HIPAA Doesn’t Apply
Published: October 24th 2017 | Updated:
When HIPAA Doesn’t ApplyPublished: November 1st 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
Roundup: Biopharmaceutical Industry Activity Accelerates with Focus on Rare Diseases and Novel Therapies
3
How are Updates to FDA's Processes Impacting Medical Affairs Teams?
4
Advancing Neuroscience and Rare Disease Innovation
5
